Cargando…
NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
A key transcription factor associated with poor prognosis and resistance to chemotherapy in ovarian cancer is NANOG. However, the mechanism by which NANOG functions remains undefined. It has been suggested that epithelial-to-mesenchymal transition (EMT) also contributes to development of drug resist...
Autores principales: | Qin, Shan, Li, Yanfang, Cao, Xuexia, Du, Jiexian, Huang, Xianghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223747/ https://www.ncbi.nlm.nih.gov/pubmed/27884977 http://dx.doi.org/10.1042/BSR20160247 |
Ejemplares similares
-
FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014) -
MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
por: Cao, Lanqin, et al.
Publicado: (2018) -
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016) -
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
por: Paranjape, Anurag N, et al.
Publicado: (2014) -
Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance
por: Zhang, Yan, et al.
Publicado: (2016)